PDS Biotechnology Corp — Director's Dealing 2020

Jun 26, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PDS Biotechnology Corp (PDSB)
CIK: 0001472091
Period of Report: 2020-06-23

Reporting Person: WOOD LAUREN (N/A)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-06-23	Employee Stock Option (Right to Buy)	$1.45	A	35000	Acquired	2030-06-23	Common Stock (35000)	Direct

Footnotes

F1: This option, representing a right to purchase a total of 35,000 shares of Common Stock, will become exercisable on June 23, 2021, with 25% vesting on that date and the remaining 75% vesting in 36 equal monthly installments thereafter, subject to continued service to the Issuer through each vesting date.